Azacitidin Stada 100 mg

Azacitidin Stada 100 mg is a medicine authorised by Swissmedic under authorisation number 69238. The authorisation holder is Spirig HealthCare AG. The medicinal product code is Synthetic medicines and the dispensing category is A: Supplied only against a medical or veterinary prescription that may not be dispensed repeatedly. First authorisation was granted on 18 September 2023 and the authorisation is limited until 17 September 2028. ATC code L01BC07 places the medicine in the group Antineoplastic agents.

  • Dispensing category A
  • Authorisation number 69238
  • ATC L01BC07
  • Synthetic medicines
Authorisation data
Authorisation number69238
NameAzacitidin Stada 100 mg
Full nameAzacitidin Stada 100 mg, Pulver zur Herstellung einer Injektionssuspension
Authorisation holderSpirig HealthCare AG
Medicinal product codeSynthetic medicines
Dispensing categoryA · Prescription, not repeatable
ATC codeL01BC07
First authorisation18 September 2023
Authorisation validity17 September 2028
Strengths
No.NameDispensing categoryAuthorisation date
1Azacitidin Stada 100 mg, Pulver zur Herstellung einer InjektionssuspensionA18 September 2023
2Azacitidin Stada 150 mg, Pulver zur Herstellung einer InjektionssuspensionA18 September 2023

Scroll the table sideways

Pack sizes
Pack codeQuantityUnitATCIT codeDispensing category
11Durchstechflasche(n)L01BC0707.16.1.A
21Durchstechflasche(n)L01BC0707.16.1.A

Scroll the table sideways

Medicines in the same ATC group

Other medicines from this authorisation holder

Frequently asked questions

Is Azacitidin Stada 100 mg authorised in Switzerland?

Yes. Azacitidin Stada 100 mg is authorised by Swissmedic under authorisation number 69238, data as of 01 September 2026. The authorisation is limited until 17 September 2028.

Which dispensing category does Azacitidin Stada 100 mg have?

Azacitidin Stada 100 mg is in dispensing category A. Supplied only against a medical or veterinary prescription that may not be dispensed repeatedly.

Who is the authorisation holder of Azacitidin Stada 100 mg?

The authorisation holder is Spirig HealthCare AG. The holder carries the legal responsibility for quality, safety and product information of the medicine in Switzerland.

Sources

Swissmedic data as of 01 September 2026. No medical advice. Independent directory, not affiliated with Swissmedic or the FOPH.

Authorisation in Switzerland?

About 2 minutes. No obligation.

First, a little about your business.

Your answers stay in this page until you send your enquiry.

What would you like to achieve?

Your project

Where can we reach you?

You can go back to review your answers before sending.

* Required fields
Prefer email? info@swissmedicinesdirectory.com